Xylem (XYL) Tops Q1 EPS by 10c, Revenues Beat; Raises FY21 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- Equity positioning stays overweight, but summer extremes have eased: Barclays
- Oil prices rise by about $1/bbl on stalled US-Iran talks and tight fuel markets
- Micron reports Q4 today: Why Lynx Equity sees massive upside
- Moderna: Citi says oncology optimism is priced in, cuts rating to sell
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- Mattel names Roger Lynch as chairman and CEO, replacing Ynon Kreiz
- HPE raises networking revenue outlook, secures $1.2B Vultr order
Goldman Sachs Upgrades Xylem (XYL) to Neutral
May 5, 2021 9:15 AM EDTGoldman Sachs analyst Brian Lee upgraded Xylem (NYSE: XYL) from Sell to Neutral with a price target of $107.00 (from $73.00).
The analyst comments "We acknowledge that our negative call here has been wrong, as we believed the company had more revenue downside risk... More
